Approval · Notice of Compliance 22914 · 2019
TAPAZOLE: Notice of Compliance 22914
Issued November 18, 2019
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 22914
- Date
- November 18, 2019
- Company
- Paladin Labs Inc
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Labelling Only
- Reason
- Update to the Product Monograph
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| TAPAZOLE | Not yet assigned | — |
Medicinal ingredients
- METHIMAZOLE 10 MG per TAB
- METHIMAZOLE 20 MG per TAB
- METHIMAZOLE 5 MG per TAB